The Rise of Genome Sequencing

Advances in genome sequencing technologies over the past decade have enabled the mapping of an individual's complete DNA sequence at exponentially reducing costs. Where whole genome sequencing cost over $100 million just 15 years ago, it can now be done for under $1,000. This reduction in sequencing costs has opened up whole genome sequencing to clinical applications. Genome sequencing is allowing clinicians to gain a deeper understanding of how genetic variations impact disease risk and treatment response in each individual.

Tailoring Treatments Based on Genetics

With whole genome sequencing becoming affordable, physicians can now identify genetic markers that make certain drugs more or less effective for a given patient. For example, certain genetic variants may cause a patient to metabolize a drug too quickly, reducing its effectiveness. Alternative treatment options can then be considered for Personalized Medicine. Genetic testing is also revealing which cancers have genetic drivers that can be targeted with newly developed precision oncology drugs. By matching the right drug to the right patient based on their tumor's genetic profile, these precision medicines have vastly improved survival rates for several hard-to-treat cancers.

Pharmacogenomics Guiding Prescriptions
One area where genetics is having an immediate impact is in the field of pharmacogenomics. Pharmacogenomics examines how an individual's genetic makeup affects their response to drugs. Everyone metabolizes drugs differently based on subtle genetic variations. By analyzing a patient's genome, physicians can predict how well or poorly they may tolerate certain medications and recommend alternative options preemptively. This helps avoid adverse drug events and improves treatment outcomes. An increasing number of drugs now include pharmacogenomic data in their labeling to help healthcare providers integrate this information into prescribing decisions.

Using Genetics to Design Lifestyle Interventions
Beyond just predicting disease risks and guiding treatments, genomic insights are assisting with disease prevention as well. Analyzing one's genome can provide clues about lifestyle habits they need to focus on or avoid to lower their genetic risk profile. For example, individuals with certain gene variants may need to be especially diligent about controlling blood pressure and cholesterol levels through diet and exercise modifications to reduce cardiovascular risk. Nutrigenomics research is revealing how people with different genetic profiles absorb and process nutrients differently. This knowledge enables designing targeted dietary and supplement plans optimized to an individual's DNA. Such personalized preventative strategies empower people to take proactive steps addressing any genetic vulnerabilities.

Overcoming the Barriers
While the promise of personalized medicine through genomics is immense, several barriers still need to be overcome for it to be routinely accessible. The cost of whole genome sequencing remains prohibitive for average patients in most healthcare systems globally. There are also concerns regarding privacy of genetic data and potential for discrimination based on genomic information without adequate policy safeguards. Integrating genomic insights into electronic medical records and supply chains also presents technical challenges healthcare providers are still solving. Regulatory approvals for new genomic tests and applications need streamlining as the field rapidly progresses. Physician education on genomics and lack of reimbursement models present additional hurdles. Concerted efforts by all stakeholders will be needed to realize personalized medicine's full potential at a population scale.

Despite the current limitations, genomic technologies have already started delivering on the vision of precision medicine. New genetic discoveries are happening at an extraordinary pace fuelled by ever-reducing sequencing costs. As the barriers to clinical application are systematically addressed, genomic information will increasingly guide disease screening, diagnoses, treatments and prevention strategies tailored for each individual. Personalized healthcare based on a patient's unique genetic makeup has the potential to revolutionize medicine. It promises dramatically improved outcomes, cost efficiencies for healthcare systems and empowered patients better able to take control of their own health trajectory. With targeted efforts across sectors, the next decade could see genomics routinely integrated into medical practices worldwide.

Get more insights on Personalized Medicine